Arthritis Research UK Launches Call for Pushing Frontiers in Health Research
Arthritis Research UK is seeking applications to a new call which aims to fund ambitious and innovative research that will make significant strides towards better management of musculoskeletal diseases.
The Pushing Frontiers in Health Research call will build on and expand previous work in the field, as well as inspiring new original research. Funded research resulting from the call will be expected to take a multidisciplinary approach to deliver these studies.
Arthritis Research UK use the term ‘arthritis’ in its broadest possible sense, to include all associated musculoskeletal (MSK) conditions affecting joints, bones and muscles (including back pain), as well as autoimmune diseases such as lupus.
There are three priority areas that this call seeks to address.
- Equity and access to MSK services (including timeliness in diagnosis and treatment)
- Evaluating system and organisational change in services for MSK and new models of care (including health and social care)
- Evaluation of non-pharmacological treatments. At this stage Arthritis Research UK are only interested in systematic reviews of promising non-pharmacological interventions for MSK conditions rather than primary research.
Any academic, clinician or allied health care professional at an eligible UK institution can apply. The lead applicant must be based at an eligible UK institution.
It is anticipated that awards made under this call will be for £50,000 up to £400,000 and up to 48 months in duration.
Outline applications must be submitted by the deadline of 7 February 2018.
Applicants will be informed of the outcome of the outline stage before the end of March 2018 and successful applicants will be invited to submit a full application with a deadline of 13 June 2018.
Click to view further information about this news alert
Want to improve your funding search skills or learn more about submitting grant applications? Join us at one of our training courses. Click here for more information.
Regards, The RESEARCHconnect team |